Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Galderma Group AG is a global dermatology company specializing in the research, development, and marketing of medical solutions in skin health. The company operates in the pharmaceuticals, medical devices, and consumer products segments, offering treatments for conditions like acne, rosacea, psoriasis, and other dermatological ailments. Founded in 1981 and headquartered in Lausanne, Switzerland, Galderma leverages an extensive global network to distribute its products across various regions. The company's strategic focus on dermatology enables it to maintain a robust portfolio of targeted therapies and skincare solutions that address both medical and aesthetic needs.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
Galderma Group AGJohnson & Johnson
Last price
CHF 191.95$273.20
Currency
CHF
USD
CHF 45B$658B
63.7041.49
CHF 3.01$6.58
-0.110.21
CHF 0.35$5.28
0.18%1.96%
Sector
HealthHealth
Employees
7,676138,200
Ticker
Fr. GALD$JNJ
Primary listing
XSWXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in Fr.GALD or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.